GlassScriptPhysician profile
Nicole Harkin
NPI 1356575724
$938.79
in general payments reported to CMS, 2019-2025
11 companies · $659 in 2025
The $659 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.04 · 2022: $29.29 · 2024: $200 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $859.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $235.13 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Heartflow, INC. | $209.73 | 2025 | |
| Cleerly, INC. | $117.43 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Novartis Pharmaceuticals Corporation | $106.96 | 2025 | |
| Dexcom, INC. | $99.04 | 2024-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $57.17 | 2025 | Repatha |
| Lilly USA, LLC | $32.86 | 2025 | Mounjaro, Zepbound |
| Medtronic Vascular, INC. | $25.04 | 2019 | |
| Sanofi-Aventis U.S. LLC | $25.00 | 2019 | |
| Esperion Therapeutics, INC. | $16.69 | 2025 | Nexletol |
| Baxter Healthcare | $13.74 | 2024 | Hillrom - Carnation Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Harkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.